ArticleHealth research policy and systems2022
Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.
Article in Health research policy and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 95 citations in OpenAlex.
- Spatiotemporal characteristics of health expenditure in mainland China during 2012-2020.BMC health services research · 2026Article
- Application of the Gratitude Intervention in the Healthcare Field: Scoping Review.Patient preference and adherence · 2026Review
- Analysis of Disease Burden and Future Trend Prediction for Iron Deficiency-Induced Abortion and Miscarriage in BRICS Countries.International journal of women's health · 2026Article
- Key Indicators of Performance-Based Payment to Physicians by Insurance Organizations in Iran.Medical journal of the Islamic Republic of Iran · 2026Article
- Drivers and barriers for the implementation of value-based healthcare in Latin America: a cross-country qualitative policy analysis.Lancet regional health. Americas · 2026Article
- Health expenditure, governance and SDG3 nexus: a longitudinal analysis in BRICS economies.Globalization and health · 2025Article
- Temporal trends in the incidence of adverse effects of medical treatment in BRICS countries from 1990 to 2021: an age-period cohort analysis.Frontiers in public health · 2025Article
- Evaluation of Medical Device Aging and Replacement Decisions within Hospital Environments: A User-Centered Approach.Risk management and healthcare policy · 2025Article
- Trend analysis of pediatric urolithiasis prevalence from 1990 to 2021 in the BRICS.Frontiers in pediatrics · 2025Article
- Temporal Trends in the Burden of Disease for Male Infertility from 1990 to 2021 in the BRICS.Risk management and healthcare policy · 2025Article
- Forecast of total health expenditure on China's ageing population: a system dynamics model.BMC health services research · 2024Article
- Health technology assessment for digital health Technologies in India: a framework for action.International journal of technology assessment in health care · 2024Article
- Evaluation of the impact of prospective payment systems on cholecystectomy: A systematic review and meta-analysis.Annals of hepato-biliary-pancreatic surgery · 2024Review
- Research priorities and trends in pulmonary tuberculosis in Latin America: A bibliometric analysis.Heliyon · 2024Article
- Catastrophic health expenditure of inpatients in emerging economies: evidence from the Indian subcontinent.Health research policy and systems · 2024Article
- Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer.Cost effectiveness and resource allocation : C/E · 2024Article
- Development of the China's list of ambulatory care sensitive conditions (ACSCs): a study protocol.Global health research and policy · 2024Article
- Trends and age-period-cohort effect on the incidence of falls from 1990 to 2019 in BRICS.Heliyon · 2024Article
- Does unequal economic development contribute to the inequitable distribution of healthcare resources? Evidence from China spanning 2001-2020.Globalization and health · 2024Article
- Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model.Cost effectiveness and resource allocation : C/E · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors at 5 institutions in 8 countries.
Funding
Abstract
backgroundThe leading emerging markets of Brazil, Russia, India, China and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. BRICS' share of global health spending and future projections will play a prominent role during the 2020s. The purpose of the current research was to examine the decades-long underlying historical trends in BRICS countries' health spending and explore these data as the grounds for reliable forecasting of their health expenditures up to 2030.
methodsBRICS' health spending data spanning 1995-2017 were extracted from the Institute for Health Metrics and Evaluation (IHME) Financing Global Health 2019 database. Total health expenditure, government, prepaid private and out-of-pocket spending per capita and gross domestic product (GDP) share of total health spending were forecasted for 2018-2030. Autoregressive integrated moving average (ARIMA) models were used to obtain future projections based on time series analysis.
resultsPer capita health spending in 2030 is projected to be as follows: Brazil, $1767 (95% prediction interval [PI] 1615, 1977); Russia, $1933 (95% PI 1549, 2317); India, $468 (95% PI 400.4, 535); China, $1707 (95% PI 1079, 2334); South Africa, $1379 (95% PI 755, 2004). Health spending as a percentage of GDP in 2030 is projected as follows: Brazil, 8.4% (95% PI 7.5, 9.4); Russia, 5.2% (95% PI 4.5, 5.9); India, 3.5% (95% PI 2.9%, 4.1%); China, 5.9% (95% PI 4.9, 7.0); South Africa, 10.4% (95% PI 5.5, 15.3).
conclusionsAll BRICS countries show a long-term trend towards increasing their per capita spending in terms of purchasing power parity (PPP). India and Russia are highly likely to maintain stable total health spending as a percentage of GDP until 2030. China, as a major driver of global economic growth, will be able to significantly expand its investment in the health sector across an array of indicators. Brazil is the only large nation whose health expenditure as a percentage of GDP is about to contract substantially during the third decade of the twenty-first century. The steepest curve of increased per capita spending until 2030 seems to be attributable to India, while Russia should achieve the highest values in absolute terms. Health policy implications of long-term trends in health spending indicate the need for health technology assessment dissemination among the BRICS ministries of health and national health insurance funds. Matters of cost-effective allocation of limited resources will remain a core challenge in 2030 as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.